Monoclonal antibody therapy for posttran
โ
Thomas M. Habermann
๐
Article
๐
2003
๐
John Wiley and Sons
๐
English
โ 162 KB
Background: Post-transplant lymphoproliferative (PT-LPD) disorder is a life-threatening complication with an incidence of 1-10%. Uniform treatment, so far, does not exist. Methods: In December 1996, five months after a liver transplant, a 43-year-old patient developed a PT-LPD with para-aortal lymph